Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07770594
NA

Effect of Dienogest in Symptomatic Endometrioma in Comparison to Combined Oral Contraceptive Pill.

Sponsor: Mst.Sumyara Khatun

View on ClinicalTrials.gov

Summary

women of 18-40 years with symptomatic endometrioma (moderate to severe dysmenorrhea with endometrioma(2-5cm),will be allocated into 2 groups-Experimental group (group A) and comparatorgroup( group B).Experimental group:Tab. Dienogest 2mg tablet once daily orally for three months. Comparator group: Combined oral contraceptive pill ,ethinyl estradiol,30mcg+desogestrel,150mcg tabletonce daily orally for three months without any interruption.. Size of endometrioma (mean diameter) by transvaginal sonography and pain score by VAS will be recorded at the end of 3rd month of therapy

Key Details

Gender

FEMALE

Age Range

18 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2025-04-17

Completion Date

2026-04-16

Last Updated

2026-08-18

Healthy Volunteers

No

Conditions

Interventions

DRUG

Tab.Dienogest 2 mg

Tab 2mg orally once daily for 3months.Size of endometrioma (mean diameter) by transvaginal sonography and pain score by VAS will be recorded at the end of 3rd month of therapy

DRUG

Combined oral contraceptive pill (ethinyl estradiol,30mcg+desogestrel,150mcg) tablet

Combined oral contraceptive pill (ethinyl estradiol,30mcg+desogestrel,150mcg) tablet once daily orally for three months without interruption.Size of endometrioma (mean diameter) by transvaginal sonography and pain score by VAS will be recorded at the end of 3rd month of therapy

Locations (1)

Bangladesh Medical University

Dhaka, Shahbag, Bangladesh